From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: Small structural changes address the mechanism of interaction at the efflux pump
- 1 January 2015
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 89, 606-615
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Potential applications for sigma receptor ligands in cancer diagnosis and therapyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2015
- Sigma‐2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral SensitivityChemMedChem, 2013
- Classes of Sigma2 (σ2) Receptor Ligands: Structure Affinity Relationship (SAfiR) Studies and Antiproliferative ActivityCurrent Pharmaceutical Design, 2012
- Sigma-2 ligands induce tumour cell death by multiple signalling pathwaysBritish Journal of Cancer, 2012
- 1‐Cyclohexyl‐4‐(4‐arylcyclohexyl)piperazines: Mixed σ and Human Δ8–Δ7 Sterol Isomerase Ligands with Antiproliferative and P‐Glycoprotein Inhibitory ActivityChemMedChem, 2010
- Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic PotentialsJournal of Medicinal Chemistry, 2009
- Pharmacology and Therapeutic Potential of Sigma1 Receptor LigandsCurrent Neuropharmacology, 2008
- The Functions and Structure of ABC Transporters: Implications for the Design of New Inhibitors of Pgp and MRP1 to Control Multidrug Resistance (MDR)Current Drug Targets, 2006
- Mining our ABCsCancer Cell, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002